SOURCE: Alliant Diagnostics, Inc.

March 05, 2007 10:06 ET

Alliant Diagnostics Effects a 10 for 1 Reverse Stock Split

BOCA RATON, FL -- (MARKET WIRE) -- March 5, 2007 -- Alliant Diagnostics, Inc. (PINKSHEETS: ADGJ) announced today that the Company has approved a 10 for 1 reverse stock split of the Company's common stock effective at the open of business, March 5, 2007. The Company's common stock will be quoted on a post-split basis at the open of the market on March 5, 2007. Alliant Diagnostics will begin trading under a new stock symbol. Alliant Diagnostics' stock will begin trading under the symbol (PINKSHEETS: ALNA) on March 5, 2007.

The company shareholders are not required to submit their stock certificates for new certificates in connection with the foregoing actions. The company's records with respect to the number of shares of common stock owned by each holder as a result of the reverse stock split will be automatically adjusted on the effectiveness. Any fractional shares existing as a result of the reverse stock split shall be rounded to the next higher whole number to those stockholders who are entitled to receive them as a consequence of the reverse stock split. On the effective date of the Amendment, each stockholder will own a reduced number of shares of our common stock, but will hold the same percentage of the outstanding shares as the stockholder held prior to the effective date of the Amendment.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations, are generally identifiable by the use of words such as "believe," "expect," "intend," "anticipate," "estimate," "project," or similar expressions. These forward-looking statements relate to, among other things, expectations of the business environment in which the Company operates, projections of future performance, potential future performance, perceived opportunities in the market, and statements regarding the Company's mission and vision. The Company's actual results, performance, and achievements may differ materially from the results, performance, and achievements expressed or implied in such forward-looking statements due to a wide range of factors which are set forth in our annual report on Form 10-KSB on file with the SEC.

Contact Information

  • For further information, contact:
    Investor Relations
    (561) 826-8000